Search PubMed⌕ Search

Biomedical subjects

E Nordman

Publications and source records attributed to E Nordman.

At least 55 records · Page 3Linked to original sources

Elective treatment of regional lymph nodes in malignant melanoma.

Malignant melanoma of Clark level II to V was studied in 96 patients. An elective dissection or elective irradiation of the regional lymph nodes was performed in 45 patients, whereas 51 patients were not treated electively. No statistically significant differences were observed as to the survival or recurrence-free time in the regional lymph nodes in either of these two patient groups. Between the patient groups with or without selective treatment, there was not any significant difference either, even when the prognosis and recurrence of the patients were correlated to the invasion level of the primary melanoma according to Clark or Breslow.

Adult↗

Prospidin combined to preoperative irradiation in head and neck cancer.

Twenty-seven patients with operable squamous cell cancer of head and neck were randomized into the study. Twelve patients received Prospidin combined to preoperative radiotherapy and fourteen patients were treated with preoperative radiotherapy alone. The daily dose of the drug was from 0.70 mg/kg to 2 mg/kg and the total dose during preoperative radiotherapy was between 1800 mg and 2250 mg with a mean of 2073 mg. The recurrence rate was in patients receiving Prospidin three out of twelve and in patients treated with irradiation alone four out of fourteen during the observation time of 33 months. In the present study Prospidin combined with preoperative radiotherapy had no advantage as compared to irradiation alone.

Cobalt Radioisotopes↗

Lymphocyte subpopulations in patients with breast cancer after postoperative radiotherapy.

The effects of radiotherapy on the immune competence of patients with mammary cancer was studied using enumeration of the various lymphocyte subpopulations as detected by monoclonal OKT antisera, lymphocyte proliferative responses to phytohemagglutinin, concanavalin A, purified protein derivative to tuberculin (PPD), and serum immunoglobulin levels. The tests were carried out in nine patients with newly diagnosed and operated mammary cancer before and after the radiation therapy, and 6 months later, and in ten patients whose mammary cancer had been diagnosed and treated at least 3 years earlier and who had remained tumor-free. The number of lymphocytes in the peripheral blood and the various T-cell subpopulations as well as the OKIa1 cells mostly representing B-cells decreased. The only population increasing were the OKM1-positive cells, mostly representing monocytes and null cells. As also described earlier, the responses to mitogens decreased because of the radiotherapy but recovered, except for the responses to PPD which remained low.

Aged↗

Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further applications for cancer imaging in man.

18F-2-fluoro-2-deoxy-D-glucose (FDG) is a novel radiopharmaceutical that has gained much interest as a cancer-seeking agent. In this paper two cases of histologically verified canine cancer, an osteosarcoma and a mammary carcinoma, are presented. After an intravenous bolus injection of FDG, accumulation of radioactivity over the neoplastic lesion was followed with a computer-guided specially collimated gamma camera. Ratios of radioactivity between tumour and control areas at 30 min were 2.8 and 2.2 for the osteosarcoma and the mammary carcinoma, respectively. In the osteosarcoma, which was imaged for 3 h, this ratio remained essentially stable. It is reasonable to assume that FDG will be suitable for cancer imaging in man.

Animals↗

Immune function in patients with ovarian carcinoma treated with irradiation or with cytostatics.

The immunocompetence of 25 patients with ovarian cancer was followed up during and after radiation or chemotherapy, by using the number of lymphocytes, E-rosette-forming cells, and mitogen responses as parameters. In comparison with chemotherapy, the irradiation caused a profound and permanent immunosuppression. In patients treated with chemotherapy, the number of E-rosette-forming cells and the mitogen responses were fewer in the patients who developed recurrence or dissemination.

Adult↗

Long-term effect of postoperative irradiation on the immune functions in patients with mammary carcinoma.

The effect of postoperative irradiation on the immune functions of 13 patients with breast carcinoma is reported, using as parameters the peripheral blood lymphocyte count, percentages of E and EAC rosette forming cells, and lymphocyte proliferative responses to PHA, Con A and PPD. After irradiation the number of peripheral blood lymphocytes was reduced during 8 months. The percentages of E and EAC rosette forming cells were not altered during the observation time of 7 to 36 months. In the proliferative responses of lymphocytes to PHA, Con A and PPD, the postoperative irradiation caused a decrease which, regarding PHA and Con A, lasted up to 8 months and then recovered. The decrease in the proliferative responses to PPD was stronger and lasted during the whole observation time. In the mitogenic responses of patients with recurrent or disseminating disease no difference could be demonstrated as compared with the patients living recurrence-free.

Adult↗

Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs.

In oncology units, personnel handling chemotherapeutic drugs may occasionally be exposed to small amounts of genotoxic agents. This exposure was obviously the cause of the increased frequencies of sister chromatid exchange (SCE) observed in nurses in daily contact with cytostatics (N = 20, mean SCEs/cell +/- SE 9.4 +/- 0.3) as compared to a group of office workers (N = 10, mean SCEs/cell 8.1 +/- 0.3). The oncology nurses also had a higher SCE frequency than other hospital nurses (N = 10, mean SCEs/cell 8.7 +/- 0.2), but this difference was not statistically significant. The SCEs of patients under chemotherapy were about five times higher (mean SCEs/cell 36.8 +/- 0.6) than those of healthy subjects.

Antineoplastic Agents↗

Prolonged BCG treatment of melanoma: does it suppress the immune capacity?

The immunological status of seven patients with disseminated melanoma during BCG scarification was followed. As parameters, the total peripheral blood leukocyte and lymphocyte counts, serum immunoglobulin levels, natural ABO blood group antibodies, lymphocyte responses in vitro to PHA and PPD, and skin reactivity against PPD and candidin were followed during a period of 2--36 months. The EAC-rosette-forming cells increased and the E-rosette-forming cells decreased during prolonged BCG therapy. The skin reactions and lymphocyte responses showed in most patients conversion from negative to positive or augmentation at the start of the therapy. Later on, however, the values in most patients dropped before disseminated disease became clinically apparent. In the only surviving patient the values first increased, remained high, and after 100 weeks treatment decreased. After 140 weeks' treatment immunological parameters are similar to pre-treatment levels. The possibility that prolonged intensive BCG treatment might eventually suppress the immune system, and thus result in an enhanced risk of dissemination of the disease, is discussed.

BCG Vaccine↗

Methotrexate concentrations in biological fluids: comparison of results obtained by radioimmunoassay and direct ligand binding radioassay.

A sensitive (sensitivity 2.2 X 10(-9) mol/l) and specific (practically no cross-reaction with circulating folates) radioimmunoassay for the determination of methotrexate concentrations in biological fluids in described and compared with a commercial competitive protein binding assay. Antiserum with high titer was produced in rabbits immunized with MTX-human serum albumin conjugate. Fitness for use in pharmacokinetic drug level determinations was shown in three patients, who received both low doses and high dose therapy combined with citrovorum factor rescue. An excellent correlation was found between plasma and urine MTX concentrations obtained by RIA and competitive protein binding assay. A two-compartment pharmacokinetic model was found adequately describing the serum decay curves, but there was a great interindividual variability in the calculated pharmacokinetic parameters.

Adult↗

Surgical treatment of local recurrences of breast carcinoma in the skin and subcutaneous tissues.

Twenty-six cases of local recurrence of breast carcinoma in the skin and subcutaneous tissues after treatment with radical excision and large skin grafts or reconstruction are presented. Seventy-seven per cent of the patients were alive 2 years after the treatment. As a chest wall recurrence of breast cancer in the absence of distant metastases does not always indicate a generalization of the disease, radical reconstructive surgery is recommended as the therapy of choice.

Adult↗

The influence of 5-fluorouracil on cellular and humoral immunity in cancer patients.

The effects of 5-fluorouracil (5-FU) on the immune functions of twelve patients with disseminated cancer were studied, using as parameters the peripheral blood lymphocyte count, serum immunoglobulin levels, titers of natural blood group antibodies, percentages of E and EAC rosette forming cells, and lymphocyte proliferative responses to PHA and PPD. No effects on the humoral immune functions or on the percentages of E and EAC rosette forming cells were observed. 5-FU caused a decrease in the proliferative responses of lymphocytes to PHA and PPD. The patients could be divided into two groups: those surviving for six months or more, and those succumbing earlier. The latter ones had already initially poor proliferative responses, particularly to PPD, and the response strongly decreased during the 5-FU treatment. In the patients with a longer survival time, the effects of 5-FU on the PPD and PHA responses were not as striking.

Antibody Formation↗